![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ACYP1 |
Gene summary for ACYP1 |
![]() |
Gene information | Species | Human | Gene symbol | ACYP1 | Gene ID | 97 |
Gene name | acylphosphatase 1 | |
Gene Alias | ACYPE | |
Cytomap | 14q24.3 | |
Gene Type | protein-coding | GO ID | GO:0006793 | UniProtAcc | P07311 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
97 | ACYP1 | P94T-E | Human | Esophagus | ESCC | 7.61e-03 | 2.78e-01 | 0.0879 |
97 | ACYP1 | P104T-E | Human | Esophagus | ESCC | 2.14e-04 | 3.32e-01 | 0.0931 |
97 | ACYP1 | P107T-E | Human | Esophagus | ESCC | 6.08e-47 | 1.01e+00 | 0.171 |
97 | ACYP1 | P126T-E | Human | Esophagus | ESCC | 9.91e-10 | 7.60e-01 | 0.1125 |
97 | ACYP1 | P127T-E | Human | Esophagus | ESCC | 3.91e-20 | 2.89e-01 | 0.0826 |
97 | ACYP1 | P128T-E | Human | Esophagus | ESCC | 1.39e-37 | 1.01e+00 | 0.1241 |
97 | ACYP1 | P130T-E | Human | Esophagus | ESCC | 3.08e-16 | 3.94e-01 | 0.1676 |
97 | ACYP1 | C04 | Human | Oral cavity | OSCC | 1.07e-21 | 1.04e+00 | 0.2633 |
97 | ACYP1 | C21 | Human | Oral cavity | OSCC | 3.05e-21 | 7.85e-01 | 0.2678 |
97 | ACYP1 | C30 | Human | Oral cavity | OSCC | 4.30e-25 | 1.07e+00 | 0.3055 |
97 | ACYP1 | C43 | Human | Oral cavity | OSCC | 8.13e-42 | 8.80e-01 | 0.1704 |
97 | ACYP1 | C46 | Human | Oral cavity | OSCC | 2.41e-27 | 6.71e-01 | 0.1673 |
97 | ACYP1 | C51 | Human | Oral cavity | OSCC | 6.83e-23 | 9.61e-01 | 0.2674 |
97 | ACYP1 | C57 | Human | Oral cavity | OSCC | 4.54e-02 | 2.76e-01 | 0.1679 |
97 | ACYP1 | C06 | Human | Oral cavity | OSCC | 4.77e-03 | 8.25e-01 | 0.2699 |
97 | ACYP1 | C07 | Human | Oral cavity | OSCC | 6.64e-05 | 5.45e-01 | 0.2491 |
97 | ACYP1 | C08 | Human | Oral cavity | OSCC | 1.21e-25 | 5.73e-01 | 0.1919 |
97 | ACYP1 | C09 | Human | Oral cavity | OSCC | 6.89e-13 | 4.80e-01 | 0.1431 |
97 | ACYP1 | LN46 | Human | Oral cavity | OSCC | 2.95e-25 | 8.72e-01 | 0.1666 |
97 | ACYP1 | SYSMH2 | Human | Oral cavity | OSCC | 1.84e-15 | 6.86e-01 | 0.2326 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0062023 | Esophagus | ESCC | Pyruvate metabolism | 32/4205 | 47/8465 | 8.11e-03 | 1.94e-02 | 9.94e-03 | 32 |
hsa0062033 | Esophagus | ESCC | Pyruvate metabolism | 32/4205 | 47/8465 | 8.11e-03 | 1.94e-02 | 9.94e-03 | 32 |
hsa006209 | Oral cavity | OSCC | Pyruvate metabolism | 31/3704 | 47/8465 | 1.74e-03 | 4.73e-03 | 2.41e-03 | 31 |
hsa0062012 | Oral cavity | OSCC | Pyruvate metabolism | 31/3704 | 47/8465 | 1.74e-03 | 4.73e-03 | 2.41e-03 | 31 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ACYP1 | SNV | Missense_Mutation | c.172N>G | p.Gln58Glu | p.Q58E | protein_coding | tolerated(0.98) | benign(0.076) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | ||
ACYP1 | SNV | Missense_Mutation | rs768589082 | c.223N>T | p.Arg75Trp | p.R75W | protein_coding | deleterious(0) | possibly_damaging(0.827) | TCGA-BH-A18L-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
ACYP1 | SNV | Missense_Mutation | c.129N>C | p.Glu43Asp | p.E43D | protein_coding | deleterious(0) | probably_damaging(0.991) | TCGA-AG-3892-01 | Colorectum | rectum adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
ACYP1 | SNV | Missense_Mutation | rs113807807 | c.319N>A | p.Asp107Asn | p.D107N | protein_coding | deleterious(0.01) | benign(0.22) | TCGA-AJ-A3EL-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ACYP1 | SNV | Missense_Mutation | c.118N>A | p.Val40Met | p.V40M | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
ACYP1 | SNV | Missense_Mutation | novel | c.260N>A | p.Ser87Tyr | p.S87Y | protein_coding | deleterious(0.01) | benign(0.254) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
ACYP1 | SNV | Missense_Mutation | c.129N>C | p.Glu43Asp | p.E43D | protein_coding | deleterious(0) | probably_damaging(0.991) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | ||
ACYP1 | SNV | Missense_Mutation | c.175N>A | p.Ala59Thr | p.A59T | protein_coding | tolerated(0.37) | benign(0.02) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | ||
ACYP1 | insertion | Frame_Shift_Ins | novel | c.387dupA | p.Ter130IlefsTer4 | p.*130Ifs*4 | protein_coding | TCGA-AX-A0J1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
ACYP1 | SNV | Missense_Mutation | novel | c.274A>G | p.Met92Val | p.M92V | protein_coding | deleterious(0.03) | probably_damaging(0.944) | TCGA-D6-6517-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | III/IV | Chemotherapy | methotrexate | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |